HNSPF
Price
$2.45
Change
+$0.29 (+13.43%)
Updated
Feb 20 closing price
Capitalization
9.59B
IXHL
Price
$1.61
Change
+$0.01 (+0.62%)
Updated
Feb 21 closing price
Capitalization
56.83M
Ad is loading...

HNSPF vs IXHL

Header iconHNSPF vs IXHL Comparison
Open Charts HNSPF vs IXHLBanner chart's image
Hansoh Pharmaceutical Group
Price$2.45
Change+$0.29 (+13.43%)
Volume$2K
Capitalization9.59B
Incannex Healthcare
Price$1.61
Change+$0.01 (+0.62%)
Volume$7.23K
Capitalization56.83M
HNSPF vs IXHL Comparison Chart
Loading...
IXHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HNSPF vs. IXHL commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HNSPF is a Hold and IXHL is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (HNSPF: $2.45 vs. IXHL: $1.61)
Brand notoriety: HNSPF and IXHL are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HNSPF: 181% vs. IXHL: 10%
Market capitalization -- HNSPF: $9.59B vs. IXHL: $56.83M
HNSPF [@Pharmaceuticals: Other] is valued at $9.59B. IXHL’s [@Pharmaceuticals: Other] market capitalization is $56.83M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.61B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HNSPF’s FA Score shows that 1 FA rating(s) are green whileIXHL’s FA Score has 0 green FA rating(s).

  • HNSPF’s FA Score: 1 green, 4 red.
  • IXHL’s FA Score: 0 green, 5 red.
According to our system of comparison, HNSPF is a better buy in the long-term than IXHL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IXHL’s TA Score shows that 2 TA indicator(s) are bullish.

  • IXHL’s TA Score: 2 bullish, 8 bearish.

Price Growth

HNSPF (@Pharmaceuticals: Other) experienced а +25.64% price change this week, while IXHL (@Pharmaceuticals: Other) price change was -9.55% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.14%. For the same industry, the average monthly price growth was +77.04%, and the average quarterly price growth was +50.35%.

Industries' Descriptions

@Pharmaceuticals: Other (-1.14% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HNSPF($9.59B) has a higher market cap than IXHL($56.8M). HNSPF YTD gains are higher at: 14.851 vs. IXHL (-24.057). HNSPF has higher annual earnings (EBITDA): 3.62B vs. IXHL (-13.64M). HNSPF has more cash in the bank: 20.9B vs. IXHL (14.6M). IXHL has less debt than HNSPF: IXHL (470K) vs HNSPF (4.13B). HNSPF has higher revenues than IXHL: HNSPF (9.97B) vs IXHL (0).
HNSPFIXHLHNSPF / IXHL
Capitalization9.59B56.8M16,880%
EBITDA3.62B-13.64M-26,522%
Gain YTD14.851-24.057-62%
P/E Ratio30.21N/A-
Revenue9.97B0-
Total Cash20.9B14.6M143,151%
Total Debt4.13B470K878,723%
TECHNICAL ANALYSIS
Technical Analysis
IXHL
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
66%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 19 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
IXHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRASX16.13-0.01
-0.06%
T. Rowe Price Asia Opportunities I
CSAZX13.98-0.10
-0.71%
Columbia Global Opportunities Inst
GAOFX20.77-0.18
-0.86%
JPMorgan Global Allocation R4
HGHRX36.72-0.47
-1.26%
Hartford Healthcare R3
APGCX59.85-1.35
-2.21%
AB Large Cap Growth C

HNSPF and

Correlation & Price change

A.I.dvisor tells us that HNSPF and RMTI have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HNSPF and RMTI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HNSPF
1D Price
Change %
HNSPF100%
N/A
RMTI - HNSPF
24%
Poorly correlated
-1.67%
AYURF - HNSPF
11%
Poorly correlated
N/A
AKAN - HNSPF
8%
Poorly correlated
+1.74%
IXHL - HNSPF
5%
Poorly correlated
+0.32%
BFRI - HNSPF
4%
Poorly correlated
-3.48%
More

IXHL and

Correlation & Price change

A.I.dvisor tells us that IXHL and ESPR have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IXHL and ESPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IXHL
1D Price
Change %
IXHL100%
+0.32%
ESPR - IXHL
23%
Poorly correlated
-1.62%
PTPI - IXHL
23%
Poorly correlated
-5.59%
YCBD - IXHL
20%
Poorly correlated
+1.47%
RDY - IXHL
14%
Poorly correlated
-0.67%
TKPHF - IXHL
11%
Poorly correlated
N/A
More